Multi-Cancer Early Detection for Health Systems: Four Adoption Models

Cover Image

The American Cancer Society estimates that over 1,600 Americans die from cancer each day.1

No longer just a technology with promise, the Galleri multi-cancer early detection (MCED) test has arrived. Learn how leading health systems are implementing cutting-edge programs to screen for cancer and intervene early.

Learn how:

  • Ochsner is using MCED tests to address social determinants of health
  • HCA Healthcare and Sarah Cannon are developing processes for comprehensive cancer care from screening to diagnosis, focusing on clinical decision support, referrals, and nurse navigation earlier in a patient’s cancer detection journey
  • Providence, a leader in genomics, is conducting enhanced screening for patients who tested positive for hereditary risk
  • Veterans Health Administration using MCED tests to improve population health

Cancer won’t wait. Learn how to screen for cancer early.


The Galleri test does not detect all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests. For Important Safety Information, visit

© 2023 GRAIL

Mar 14, 2023
Mar 14, 2023
White Paper
Already a Bitpipe member? Log in here

Download this White Paper!